US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist
  • 0.5260
  • +0.0058+1.11%
Trading Dec 12 12:57 ET
3.57MMarket Cap-0.41P/E (TTM)

About Protagenic Therapeutics Company

Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Company Profile

SymbolPTIX
Company NameProtagenic Therapeutics
Listing DateApr 27, 2021
Issue Price4.50
Founded1994
CEODr. Garo H. Armen, Pd.D
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address149 Fifth Avenue,Suite 500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-994-8200
Websitehttp://www.protagenic.com

Company Executives

  • Name
  • Position
  • Salary
  • Andrew Slee
  • Chief Operating Officer
  • --
  • Dr. Robert B. Stein, M.D.,PhD
  • Director and Chief Medical Officer
  • --
  • Dr. Alexander K. Arrow, M.D.
  • Chief Financial Officer
  • 150.00K
  • Dr. Garo H. Armen, Pd.D
  • Executive Chairman of the Board and Principal Executive Officer
  • --
  • Dr. Jennifer S. Buell, PhD
  • Director
  • --
  • Khalil Barrage
  • Independent Director
  • --
  • Brian J. Corvese
  • Independent Director
  • --
  • Timothy R. Wright
  • Lead Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data